According to a statement by the HKSAR government on Nov 20, the Secretary for Food and Health (SFH) of the Hong Kong Special Administrative Region (HKSAR) government has approved extending the age eligibility of China's Sinovac COVID-19 vaccine to cover those aged three to 17.
The SFH also agreed adolescents aged 12 to 17 will be accorded priority to receive the Sinovac COVID-19 vaccine, with a view to extending to children of a younger age group at a later stage.
With reference to the advice of the Advisory Panel on COVID-19 Vaccines and having considered the threat to public health posed by COVID-19, the SFH considered that the benefits of approving the extension of the age eligibility of the Sinovac vaccine to cover those aged three to 17 outweigh the risks. The SFH added that doing so can protect them from COVID-19 infection and also enable them to resume normal school and daily life as soon as possible.
Sources: China Daily, Xinhua
点击右上角微信好友
朋友圈
请使用浏览器分享功能进行分享